Manulife US Reit lowers Q4 DPU on enlarged unit base
MANULIFE US Real Estate Investment Trust's (Manulife US Reit) distribution per unit (DPU) fell 5.9 per cent to 1.44 US cents for its fourth quarter ended Dec 31, 2019, from 1.53 cents a year ago.
This was mainly due to an enlarged unit base following a placement and preferential offering to partially fund its US$198.8 million acquisition of 400 Capitol Mall, it said in a bourse filing on Wednesday.
Gross revenue increased 20.4 per cent to US$48.8 million for the quarter, from US$40.5 million on the back of contributions from the newly acquired Centerpointe and Capitol properties.
Net property income (NPI) grew 18.9 per cent on the year to US$30.3 million from US$25.5 million.
Distributable income for Q4 climbed 15.5 per cent year on year to US$22.6 million from US$19.6 million.
Unitholders will receive a total distribution of 1.45 US cents per unit on March 27, after books closure on Feb 13.
The 1.45 US cents comprise the Q4 DPU of 1.44 US cents as well as an additional 0.01 US cent for Sept 30, 2019. The 0.01 US cent is the balance remaining from the Q3 DPU.
Meanwhile, for fiscal 2019 ended Dec 31, DPU rose 7 per cent to 5.96 US cents from 5.57 US cents a year ago. Gross revenue jumped 23 per cent to US$177.9 million from US$144.6 million. NPI jumped 22.2 per cent to US$110.8 million from US$90.7 million.
Jill Smith, chief executive officer of the Reit's manager, said 2019 was Manulife US Reit's best year, and its acquisitions of four office properties in strong US growth markets in the past two years diversified the Reit's NPI and positively contributed to its growth.
Manulife US Reit units closed up US$0.04 or 3.9 per cent to US$1.07 on Tuesday.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance